BRIEF RESEARCH REPORT article
Front. Oncol.
Sec. Pediatric Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1620316
This article is part of the Research TopicInnovations in Supportive Care in Global Pediatric OncologyView all 3 articles
Improving Fever Management of Hospitalized Children with Cancer: Barriers, Facilitators, and Proposed Interventions from Healthcare Providers in Kenya
Provisionally accepted- 1School of Arts and Social Sciences, Moi University, Eldoret, Kenya
- 2Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, United States
- 3Fogarty International Center, National Institutes of Health, Bethesda, United States
- 4Department of Global Health, University of Washington, Seattle, United States
- 5Academic Model for Providing Access to Healthcare, Eldoret, Kenya
- 6Vrije Universiteit, Amsterdam, Netherlands
- 7Pediatric Hematology/Oncology, University of North Carolina, Chapel Hill, United States
- 8Moi Teaching and Referral Hospital, Eldoret, Kenya
- 9Pediatric Hematology/Oncology, Indiana University, Indianapolis, United States
- 10Departmet of Learning Health Sciences, University of Michigan, Ann Arbor, United States
- 11Department of Child Health and Pediatrics, Moi University, Eldoret, Kenya
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Children with cancer in lower-middle income countries (LMIC) are at increased risk of dying from infections. Prompt treatment of fever episodes improves outcomes, yet poorly described challenges impair management. This qualitative study explored healthcare provider perspectives of the barriers to and facilitators of inpatient fever management in children with cancer at a public tertiary referral children’s hospital in Kenya. Healthcare providers involved in fever management were recruited. Semi-structured interviews were audio recorded, transcribed verbatim, then entered into NVivo software. Coding was informed by a theoretical fever framework and the Consolidated Framework for Implementation Research. Thematic analysis and mind mapping identified recurrent themes and subthemes. Mapping of strategies to barriers was performed. Sixteen participants included nurses (2), clinicians (6), pharmacists (2), phlebotomists (2), and microbiology lab staff (4). We identified three overarching themes: empowerment of healthcare providers and caregivers, the importance of timely management, and teamwork / human resource availability. Healthcare provider attributes were facilitators: motivation to improve care, eagerness to learn, willingness to change practice, and need for treatment guidance. Factors within the hospital system were barriers, with subthemes of poor communication between cadres, delays in lab results, and staffing shortages. Participants suggested knowledge sharing, a treatment guideline, task shifting, and hiring additional healthcare providers as interventions. Fever episode management in children with cancer is complex, requiring multiple cadres of healthcare providers and caregiver participation. The proposed interventions may overcome barriers, but future studies are needed to measure the outcomes of the strategies in improving fever management.
Keywords: Febrile neutropenia, pediatric oncology, antibiotic, Blood stream infection, guideline, implementation science
Received: 29 Apr 2025; Accepted: 18 Aug 2025.
Copyright: © 2025 Kisembe, Nessle, Dettinger, Nyamusi, Kinja, Ndung'u, Langat, Busby, Olbara, Vik, Moyer and Njuguna. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
C. Nathan Nessle, Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, United States
Festus Njuguna, Department of Child Health and Pediatrics, Moi University, Eldoret, Kenya
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.